These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 17240485

  • 1. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M, Cabrera O, Martinez I, Del Campo JM, Camaraza MA, Sotolongo F, Pérez O, Sierra G.
    Vaccine; 2007 Feb 26; 25(10):1798-805. PubMed ID: 17240485
    [Abstract] [Full Text] [Related]

  • 2. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
    Carmenate T, Guirola M, Alvarez A, Canaán L, González S, Caballero E, Menéndez T, Guillén G.
    FEMS Immunol Med Microbiol; 2005 Feb 01; 43(2):133-40. PubMed ID: 15681142
    [Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.
    Lee CH, Kuo WC, Beri S, Kapre S, Joshi JS, Bouveret N, LaForce FM, Frasch CE.
    Vaccine; 2009 Jan 29; 27(5):726-32. PubMed ID: 19063929
    [Abstract] [Full Text] [Related]

  • 4. Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine.
    Zhang T, Yu W, Wang Y, Hu T.
    Vaccine; 2015 Jun 22; 33(28):3208-14. PubMed ID: 25964170
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK, Lee CH, Norris SE, Paul-Satyaseela M, Vann WF, Frasch CE.
    Vaccine; 2007 Nov 14; 25(46):7972-80. PubMed ID: 17936445
    [Abstract] [Full Text] [Related]

  • 6. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.
    Carmenate T, Canaán L, Alvarez A, Delgado M, González S, Menéndez T, Rodés L, Guillén G.
    FEMS Immunol Med Microbiol; 2004 Apr 09; 40(3):193-9. PubMed ID: 15039094
    [Abstract] [Full Text] [Related]

  • 7. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ, Roy R, Gamian A.
    J Immunol; 1986 Sep 01; 137(5):1708-13. PubMed ID: 3091688
    [Abstract] [Full Text] [Related]

  • 8. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J, Deane S, Ashton L, Borrow R, Goldblatt D, Andrews N, Balmer P, Morris R, Kroll JS, Miller E.
    Clin Diagn Lab Immunol; 2004 Nov 01; 11(6):1100-4. PubMed ID: 15539513
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
    Beuvery EC, Roy R, Kanhai V, Jennings HJ.
    Dev Biol Stand; 1986 Nov 01; 65():197-204. PubMed ID: 3104115
    [Abstract] [Full Text] [Related]

  • 10. Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid.
    Silveira IA, Bastos RC, Neto MS, Laranjeira AP, Assis EF, Fernandes SA, Leal ML, Silva WC, Lee CH, Frasch CE, Peralta JM, Jessouroun E.
    Vaccine; 2007 Oct 10; 25(41):7261-70. PubMed ID: 17719147
    [Abstract] [Full Text] [Related]

  • 11. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.
    Qiao W, Ji S, Zhao Y, Hu T.
    Vaccine; 2015 Apr 21; 33(17):2066-72. PubMed ID: 25728319
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO, Dias WO, Schenkman RP, Raw I, Tanizaki MM.
    FEMS Immunol Med Microbiol; 2004 Jul 01; 41(3):205-10. PubMed ID: 15196569
    [Abstract] [Full Text] [Related]

  • 13. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
    Shapiro DA, Threadgill DS, Copfer MJ, Corey DA, McCool TL, McCormick LL, Magnuson TR, Greenspan NS, Schreiber JR.
    J Immunol; 1998 Oct 01; 161(7):3393-9. PubMed ID: 9759856
    [Abstract] [Full Text] [Related]

  • 14. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.
    Rubinstein LJ, García-Ojeda PA, Michon F, Jennings HJ, Stein KE.
    Infect Immun; 1998 Nov 01; 66(11):5450-6. PubMed ID: 9784556
    [Abstract] [Full Text] [Related]

  • 15. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.
    Beuvery EC, Speijers GJ, Lutz BI, Freudenthal D, Kanhai V, Haagmans B, Derks HJ.
    Dev Biol Stand; 1986 Nov 01; 63():117-28. PubMed ID: 3091432
    [Abstract] [Full Text] [Related]

  • 16. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ, Lugowski C.
    J Immunol; 1981 Sep 01; 127(3):1011-8. PubMed ID: 6790606
    [Abstract] [Full Text] [Related]

  • 17. Mucosal immune responses to meningococcal C polysaccharide-protein conjugate in mice.
    Cuello M, Cabrera O, del Campo JM, Parajón E, Sotolongo F, Camaraza MA, Arnet A, Suárez M, Pérez O.
    Vaccine; 2006 Apr 12; 24 Suppl 2():S2-72-3. PubMed ID: 16823934
    [Abstract] [Full Text] [Related]

  • 18. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, Poolman J, Boutriau D.
    Vaccine; 2007 Dec 12; 25(51):8487-99. PubMed ID: 17996996
    [Abstract] [Full Text] [Related]

  • 19. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
    Prinz DM, Smithson SL, Westerink MA.
    J Immunol Methods; 2004 Feb 01; 285(1):1-14. PubMed ID: 14871530
    [Abstract] [Full Text] [Related]

  • 20. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H, Heath PT, Papa T, Ruggeberg JU, Johnson N, Sinha R, Balfour G, Booy R.
    Vaccine; 2006 Mar 24; 24(14):2544-9. PubMed ID: 16417952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.